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Quinocarcin and SF-1739, potent antitumor antibi-
otics, share a common tetracyclic tetrahydroisoqui-
noline (THIQ)-pyrrolidine core scaffold. Herein, we
describe the identification of their biosynthetic
gene clusters and biochemical analysis of Qcn18/
Cya18 generating the previously unidentified ex-
tender unit dehydroarginine, which is a component
of the pyrrolidine ring. ATP-inorganic pyrophosphate
exchange experiments with five nonribosomal pep-
tide synthetases (NRPSs) enabled us to identify their
substrates. On the basis of these data, we propose
that a biosynthetic pathway comprising a three-
component NRPS/MbtH family protein complex,
Qcn16/17/19, plays a key role in the construction
of tetracyclic THIQ-pyrrolidine core scaffold in-
volving sequential Pictet-Spengler and intramolecu-
lar Mannich reactions. Furthermore, data derived
fromgene inactivation experiments led us to propose
late-modification steps of quinocarcin.
INTRODUCTION
Quinocarcin (1) is a potent antitumor agent isolated from Strep-
tomyces melanovinaceus DO-52 (Takahashi and Tomita, 1983;
Tomita et al., 1983), and is known to inhibit the migration of
epithelial cells (Figure 1) (Kahsai et al., 2006). Its potent antitumor
activity derives from the iminium ion via a carbinolamine moiety
and its equivalents, which directly alkylate the DNA in the minor
groove. Naphthyridinomycin (Sygusch et al., 1974) isolated from
S. griseoplanus SF-1739 (2) (Itoh et al., 1982; Watanabe et al.,
1976) is structurally related to quinocarcins and is one of the first
members of its related isolated alkaloids. It has a complex hex-
acyclic structure, and the combination of its unique structure of
quinocarcins with their potent antitumor activity has prompted
extensive studies of their synthesis and structure-activity rela-
tionship (Scott and Williams, 2002). These metabolites belongChemistry & Biology 20, 1523–153to the tetrahydroisoquinoline (THIQ) antibiotic family (Scott and
Williams, 2002) represented by saframycin A (Sfm A) (Arai
et al., 1977). Among THIQ members, ecteinascidin-743 (ET-
743) exhibits the most potent antitumor activity and recently
has been approved as an anticancer drug (Fayette et al., 2005;
Sakai et al., 1992). Biosynthetically, THIQ family members are
divided into two groups: those that possess the bisTHIQ scaffold
(I: Sfm, ET-743) and those with the THIQ-pyrrolidine core scaf-
fold (II: 1 and 2) (Figure 1A). Feeding experiments of isotopically
labeled precursors (Palaniswamy and Gould, 1986) and identifi-
cation of gene clusters indicated that the backbones of these
metabolites are constructed by nonribosomal peptide synthe-
tase (NRPS) (Li et al., 2008; Velasco et al., 2005).
In general, nonribosomal peptide synthetase (NRPS) consists
of several modules comprising an assembly line of functionally
defined domains for condensation (C), amino acid adenylation/
thiolation (A), and the amino acid/peptidyl carrier protein
(PCP)-transferring extender unit or product among individual
catalytic domains (Finking and Marahiel, 2004; Fischbach and
Walsh, 2006). NRPS substrates and intermediates are always
tethered to the PCP domain until the final cleavage with the
domain for hydrolysis (TE) or reduction (R) after a defined number
of condensations. This organized assembly line determines the
amino acid sequence of the product. Recently, we succeeded
in demonstrating an in vitro enzymatic synthesis of a Sfm penta-
cyclic core scaffold with a single NRPSSfmC using a simple fatty
acyl-dipeptidyl-coenzyme A (CoA) and a modified tyrosine
analogue (Koketsu et al., 2010, 2012a, 2012b) (Figure 1B). In
Sfm biosynthesis, three modules initially follow the conventional
assembly line logic. However, NRPS SfmC violates this logic
due to the involvement of several unusual features, such as an
iterative use of a single module, multiple reductive cleavage of
condensation products with the R domain, and two rounds of
Pictet-Spengler (PS) reactions with the C domain (Figure 1B).
Structural similarity between bisTHIQ and THIQ-pyrrolidine
members suggests that the THIQ-pyrrolidine scaffold would be
constructed by a similar NRPS system. Although biosynthetic
building units of 2 have been determined (L-Orn, L-Ser, and
modified tyrosine analogue) (Palaniswamy and Gould, 1986;
Zmijewski, 1985; Zmijewski et al., 1982, 1985), a detailed biosyn-
thetic pathway of its highly unusual molecular skeleton has not5, December 19, 2013 ª2013 Elsevier Ltd All rights reserved 1523
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Figure 1. Chemical Structures of Tetrahydroisoquinoline Antitumor Antibiotics and Saframycin Biosynthesis
(A) Chemical structures of bisTHIQ members (saframycin type (I) and THIQ-pyrrolidine (quinocarcin type; II).
(B) Biosynthetic pathway of saframycin.
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from 2 gives essentially the same core scaffold as that of 1 (Fig-
ure S9 available online). Therefore, the molecular assembly
mechanisms of 1 and 2 should be similar to each other and
more complicated than that of Sfm, because the last two intra-
molecular cyclizations require two different amino acids, unlike
SfmC, which requires only the modified tyrosine analogue (Fig-
ure 1B). To genetically engineer the THIQ core skeleton, we
started to investigate the construction mechanism of the THIQ-
pyrrolidine scaffold found in 1 and 2. Herein we describe the
identification of two gene clusters for 1 and 2, functional analysis1524 Chemistry & Biology 20, 1523–1535, December 19, 2013 ª2013of an enzyme responsible for key nonproteinogenic amino acid
biosynthesis, and quinocarcin NRPS A domains. We also pro-
pose a molecular assembly mechanism of this highly unusual
NRPS complex.
RESULTS AND DISCUSSION
Gene Cluster Identification of Quinocarcin and SF-1739
PCR amplification with degenerate PCR primers designed on the
basis of a conserved region of the A-PCP-R domain on SfmC
and using S. griseoplanus SF-1739 genomic DNA as a templateElsevier Ltd All rights reserved
Figure 2. Gene Clusters of Quinocarcin (1) and SF-1739 (2)
Genetic organization of the quinocarcin biosynthetic gene clusters (S. melanovinaceus DO-52) and the SF-1739 biosynthetic gene clusters (S. griseoplanus
SF-1739).
See also Table 1 and Table S1.
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Quinocarcin Biosynthetic Core Assembly Mechanismyielded an expected 1.8 kb PCR fragment covering the A3-R5
motif region (Marahiel et al., 1997), which showed 46%
sequence identity to the saframycin Mx1 synthetase A gene
(Pospiech et al., 1996). Using this fragment as a probe,
desired fosmids were screened from the SF-1739 producer
genome library. The isolated fosmids, pSFK007, pSFK009, and
pSFK021, were sequenced. We obtained the total 54 kb
sequence covering the putative SF-1739 biosynthetic gene clus-
ter (Figure 2 and Table 1). FramePlot and BLAST analyses
(National Institutes of Health, Bethesda, MD, USA) revealed
that the gene cluster contained 28 open reading frames (ORFs).
Among that cluster, 11 genes showed a relatively high sequence
similarity with safracin and Sfm biosynthetic genes (Figure 2 and
Table 1; Table S1) (Li et al., 2008; Velasco et al., 2005).
Because 1 and 2 share nearly the same core skeleton, we
expected that comparison of the SF-1739 and quinocarcin
gene clusters would enable us to identify specific genes
responsible for THIQ-pyrrolidine core assembly. In particular,
the biosynthetic genes of structurally simple 1 help to eliminate
the modification genes in the late-stage biosynthesis of 2.
To obtain the corresponding quinocarcin gene cluster, we
sequenced the genome of the quinocarcin-producing strain
S. melanovinaceus DO-52. Sequence analysis of the draft
genome sequence with the putative SF-1739 biosynthetic genes
enabled us to identify the putative quinocarcin gene cluster,
which spans 37 kb on a single contig and consists of 24
ORFs (Figure 2; Table 1).
Among the ORFs in both clusters, 13 share significant homol-
ogy (38%–70% identity) with those of the SF-1739 gene cluster.
Of these ORFs, six encoded NRPS-related genes (qcn12/13/15/
16/17/19 and cya12/13/15/16/17/19), three encoded genes for
unusual extender unit biosynthesis (qcn7/8/9; cya26/25/24 for
glycolic acid unit) (Peng et al., 2012), and two encoded resis-
tant/auxiliary genes (qcn6/14 and cya29/14) (Table 1; Table
S1). There were two unassigned ORFs: qcn18/cya18 (monooxy-
genase) and qcn10/cya23 (b-ketoacyl-acyl carrier protein syn-
thase III [KASIII]). In addition, there are genes (qcn11/cya5) that
reveal a moderate homology (19%/31%, respectively) with the
N-methyltransferase gene sacI. On the basis of the bioinformatic
and experimental data described later, we propose functions of
biosynthetic genes, which are given in Figure 3.
Gene Inactivation Experiments
To verify the function of these putative quinocarcin biosynthetic
genes, we performed several gene inactivation experiments,
which are described in the Supplemental Information availableChemistry & Biology 20, 1523–153online (Figure S1 and Table S2). As anticipated, inactivation of
qcn7 (precursor supply) and qcn19 (NRPS) completely abolished
production of 1, indicating that these genes are essential for qui-
nocarcin biosynthesis. On the one hand, a significant decrease in
quinocarcin production was observed in both qcn14 (Type II
thioesterase) and qcn1 (peptidase) disruptant strains; on the
other hand, inactivation of qcn2/3, which encode the putative
oxygenase genes, caused accumulation of novel metabolites
(Figure 4).
Under standard fermentation conditions, S. melanovinaceus
produced 1 and its reduced form, quinocarcinol (3) (Takahashi
and Tomita, 1983), in a 1:5.7 ratio. The qcn2/3 disruptant strain
significantly reduced the ability to produce these metabolites
and instead accumulated two compounds: 5a and 5b (Fig-
ure 3C). Although 1H and 13C nuclear magnetic resonance
(NMR) spectra of the major product 5bwere very similar to those
of 3 (Figure S2 and Table S3), significant differences in the NMR
signals were observed. Signals derived from the carboxyl group
disappeared; instead, the new signals corresponding to the
methylene group appeared (dC 67.26; dH 3.62, 3.58), indicating
replacement of the functional group (CO2H to CH2OH) in 5b.
The molecular formula C18H26N2O3 for 5b was consistent with
this change. Extensive NMR spectroscopy analysis confirmed
the structure of 5b, which is shown in Figure 3C. Comparison
of the 1H NMR spectra of 5a and 5b showed disappearance of
the N-methyl signal at 2.55 ppm in 5a (Figure S3 and Table
S3). This observation is in accord with the molecular formula
C17H24N2O3, indicating that 5a is a desmethyl analogue of 5b.
Production of 1 inS.melanovinaceusDO-52 always accompa-
nied its reduced product, 3. In addition, we found that the wild-
type produced trace amounts of alcohols 5a and 5b, suggesting
that the wild-type can convert a putative intermediate 5c to the
products reducing both aminoacetal and aldehyde moieties.
Thus, detection of a significant amount of 5a and 5b in the dis-
ruptant strain suggests that the disruption of qcn2/3 caused
accumulation of aldehyde 5c, which is reduced to produce the
alcohols by an unidentified reductase, although 5c is rapidly
oxidized to the corresponding acid 1 in the wild-type. These
data indicate that the putative dehydrogenases Qcn2/3 are
responsible for oxidation of 5c to 1. Detection of acid 3 in the dis-
ruptant strain is difficult to explain, but it might be that an oxidase
other than Qcn2/3 converts part of 5c into 3.
Biosynthesis of Unusual Extender Units
Quinocarcin/SF-1739 biosynthesis requires several unusual
extender units, including glycolic acid and aromatic and aliphatic5, December 19, 2013 ª2013 Elsevier Ltd All rights reserved 1525
Table 1. Proposed Functions of Biosynthetic Genes for Quinocarcin and SF-1739
Cluster
Gene
size (bp) Proposed Function Homolog
Identity/
Similality (%)
Quinocarcin cluster
ORF1 252 transposase WP_007387627 [Streptomyces coelicoflavus] 68/75
ORF2 639 endonuclease III WP_009713572 [Streptomyces himastatinicus] 71/83
ORF3 600 DNA ligase D WP_004579877 [Marinobacter nanhaiticus] 55/72
Qcn1 1,479 peptidase WP_005158957 [Amycolatopsis azurea] 49/60
Qcn2 2,742 dehydrogenase subunit WP_008971594 [Bradyrhizobium sp. STM 3843] 45/58
Qcn3 948 dehydrogenase subunit WP_009028314 [Bradyrhizobium sp. ORS 375] 43/57
Qcn4 879 monooxygenase YP_003301288 [Thermomonospora curvata DSM 43183] 56/69
Qcn5 630 methyltransferase WP_003922721 [Mycobacterium xenopi] 35/52
Qcn6 2,595 UV repair protein ABI22122 [Streptomyces lavendulae] 61/74
Qcn7 972 dehydrogenase a-subunit NP_625557 [Streptomyces coelicolor A3(2)] 68/76
Qcn8 231 phosphopantetheine binding protein YP_003835760 [Micromonospora aurantiaca ATCC 27029] 52/66
Qcn9 2,184 dehydrogenase b-subunit NP_625556 [Streptomyces coelicolor A3(2)] 53/67
Qcn10 1,035 KASIII-like protein WP_007461640 [Micromonospora lupini] 50/61
Qcn11 738 N-methyltransferase WP_003952663 [Streptomyces clavuligerus] 40/55
Qcn12 3,249 NRPS/C, A, PCP YP_004668223 [Myxococcus fulvus HW-1] 43/57
Qcn13 2,205 acylligase, ACP WP_006510835 [Xenococcus sp. PCC 7305] 40/55
Qcn14 795 type II TE YP_607770 [Pseudomonas entomophila L48] 41/56
Qcn15 3,372 NRPS/C, A0, PCP AAC44129 [Myxococcus xanthus] 37/52
Qcn16 210 MbtH-like protein WP_020553649 [Streptomyces scabrisporus] 66/79
Qcn17 4,461 NRPS/PS, A, PCP, R AAC44129 [Myxococcus xanthus] 41/57
Qcn18 1,035 dioxygenase YP_007524553 [Streptomyces davawensis JCM 4913] 46/63
Qcn19 2,718 NRPS/C0, A YP_007206804 [Singulisphaera acidiphila DSM 18658] 39/52
Qcn20 873 regulator (AfsR family) WP_008745069 [Streptomyces sp. SPB74] 50/64
Qcn21 528 regulator (Xre family) CAG34721 [Streptomyces ribosidificus] 75/82
Qcn22 519 regulator CAG38710 [Streptomyces lividus] 58/69
Qcn23 1,233 regulator ADZ45347 [Streptomyces sp. NRRL 30471] 43/57
Qcn24 1,290 transporter WP_017250942 [Brevibacillus brevis] 33/55
ORF4 456 N-acetyltransferase WP_003952604 [Streptomyces clavuligerus] 81/85
ORF5 405 transposase WP_005477291 [Streptomyces bottropensis] 88/90
ORF6 855 hypothetical protein WP_005320224 [Streptomyces pristinaespiralis] 87/92
SF-1739 cluster
ORF1 414 hypothetical protein WP_006376439 [Streptomyces turgidiscabies] 73/80
Cya1 666 regulator (MerR family) WP_010352886 [Streptomyces acidiscabies] 59/71
Cya2 351 regulator (TetR family-like) WP_020123521 [Streptomyces canus] 45/60
Cya3 660 phosphopantetheinyl transferase WP_010043002 [Streptomyces chartreusis] 78/85
Cya4 936 short-chain dehydrogenase YP_289303 [Thermobifida fusca YX] 77/88
Cya5 843 methyltransferase WP_010358731 [Streptomyces acidiscabies] 54/67
Cya6 1,623 oxidoreductase WP_003964492 [Streptomyces griseus] 48/62
Cya7 1,590 transporter WP_010568567 [Leptospira broomii] 51/70
Cya8 1,047 methyltransferase ABI22145 [Streptomyces lavendulae] 48/58
Cya9 1,065 methyltransferase ABI22137 [Streptomyces lavendulae] 68/79
Cya10 1,056 hypothetical protein ABI22134 [Streptomyces lavendulae] 52/63
Cya11 726 hypothetical protein YP_005281900 [Gordonia polyisoprenivorans VH2] 38/56
Cya12 9,297 NRPS/(C, A, PCP) 3 3 YP_007359073 [Myxococcus stipitatus DSM 14675] 40/54
Cya13 1,980 acylligase, ACP YP_004965445 [Streptomyces bingchenggensis BCW-1] 44/54
Cya14 774 type II thioesterase WP_006512867 [Leptolyngbya sp. PCC 7375] 37/55
Cya15 3,108 NRPS/C, A0, PCP YP_005370366 [Corallococcus coralloides DSM 2259] 33/47
(Continued on next page)
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Table 1. Continued
Cluster
Gene
size (bp) Proposed Function Homolog
Identity/
Similality (%)
Cya16 201 MbtH-like protein WP_020553649 [Streptomyces scabrisporus] 73/85
Cya17 4,455 NRPS/PS, A, PCP, R AAC44129 [Myxococcus xanthus] 43/58
Cya18 1,005 dioxygenase YP_007524553 [Streptomyces davawensis JCM 4913] 48/59
Cya19 2,649 NRPS/C0, A YP_007206804 [Singulisphaera acidiphila DSM 18658] 42/55
Cya20 1,800 regulator YP_003339454 [Streptosporangium roseum DSM 43021] 41/57
Cya21 2,631 peptidase ABI22135 [Streptomyces lavendulae] 37/47
Cya22 513 hypothetical protein WP_007506104 [Streptomyces zinciresistens] 77/88
Cya23 1,005 KASIII-like protein YP_004085355 [Micromonospora sp. L5] 54/67
Cya24 2,196 dehydrogenase b-subunit YP_003342293 [Streptosporangium roseum DSM 43021] 59/69
Cya25 258 phosphopantetheine-binding protein YP_003835760 [Micromonospora aurantiaca ATCC 27029] 59/71
Cya26 1,017 dehydrogenase a-subunit ACR50771 [Streptomyces longisporoflavus] 66/74
Cya27 1,479 monooxygenase ABI22123 [Streptomyces lavendulae] 54/66
Cya28 1,263 phosphodiesterase WP_006381602 [Streptomyces turgidiscabies] 54/64
Cya29 2,493 UV repair protein ABI22122 [Streptomyces lavendulae] 61/74
ORF2 411 N-acetyltransferase WP_016574636 [Streptomyces albulus] 79/88
ORF3 1,062 L-kynurenine hydrolase WP_004936321 [Streptomyces griseoflavus] 88/91
Common genes for core assembly are shown in boldface. See also Figure S5 and Table S1.
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Quinocarcin Biosynthetic Core Assembly Mechanismamino acids. Incorporation of isotopically labeled precursors
confirmed involvement of L-3-hydroxy-5-methyl-O-methyltyro-
sine (4) in the core skeleton assembly of 2 (Palaniswamy and
Gould, 1986; Zmijewski, 1985; Zmijewski et al., 1982, 1985).
This indicated that either L-3-hydroxyphenylalanine (m-Tyr) or
itsO-methylated analogue is an alternative for the core assembly
of 1 (Figure 3A). In the biosynthetic study of safracin, involvement
of sacD, sacF, and sacG genes in the generation of 4 were
established by cocultivation of individual deletion mutants with
sacD/E/F/G/H transformants (Figure 3D) (Velasco et al., 2005).
Comparison of the cya8, cya9, and cya10 genes revealed a rela-
tively high homology to the genes sacD/sfmD (hydroxylase),
sacF/sfmM2 (C-methyltransferase), and sacG/sfmM3 (O-meth-
yltransferase), which are involved in the biosynthesis of safra-
cin/saframycin (Table S1) (Li et al., 2008; Velasco et al., 2005).
Recently, an in vitro study on SfmD and SfmM2 showed that
SfmD is a heme-containing peroxidase specific to L-3-methyltyr-
osine that is derived from L-Tyr byCmethylation with SfmM2 (Fu
et al., 2009; Tang et al., 2012). Themonooxygenase gene qcn4 is
homologous (41% identity) to the tetrahydrobiopterin-depen-
dent aromatic amino acid hydroxylase gene pacX, which is
responsible for m-Tyr formation in pacidamycin biosynthesis
(Kaysser et al., 2011; Zhang et al., 2011). A putative methyltrans-
ferase gene, qcn5, is homologous to O-methyltransferases
belonging to the catechol O-methyltransferase family (Martin
and McMillan, 2002), indicating that qcn5 is responsible for
O-methylation of the m-Tyr unit either before or after backbone
construction (Figure 3C).
Recently, Tang and coworkers biochemically characterized a
set of genes supplying the glycolyl unit of 1 (Peng et al., 2012).
Two-component transketolases qcn7/9 (qncN/L) transfer a
hydroxyethyl group fromD-xylulose-5-phosphate to the discrete
acyl carrier protein (ACP) qcn8 (qncM). Other gene clusters of
THIQ that have the glycolyl unit, such as 2 and ET-743, possessChemistry & Biology 20, 1523–153the homologs cya24/25/26 (napB/C/D) and etuP1/P2 (Rath et al.,
2011).
The remaining extender unit is an aliphatic amino acid consist-
ing of a quinocarcin/SF-1739 pyrrolidine ring. Reported 13C-
feeding experiments have established that L-Orn is a precursor
of the right half of the SF-1739 core scaffold (Zmijewski et al.,
1982). The established mechanism of saframycin suggests that
oxidation at a g-position of L-Orn is required for formation of
the pyrrolidine ring (Figure 3A). We speculated that cya18/
qcn18 is a candidate gene that showed relatively high sequence
similarity (34%–45% identity) to the gene encoding the enzymes
that promote hydroxylation targeting the b-position of several
amino acids, such as AsnO (L-Asn) (Strieker et al., 2007), VioC
(L-Arg) (Yin and Zabriskie, 2004), and MppO (L-enduracididine)
(Haltli et al., 2005). To verify this hypothesis, in vitro assays
with recombinant Cya18 and Qcn18 were conducted using
several substrates, including L-Orn.
We cloned and overexpressed Cya18 as a hexahistidine-
tagged protein in Escherichia coli BL21(DE3). The recombinant
Cya18 was purified using nickel nitrilotriacetic acid (Ni-NTA)
resin. The identity of this protein was confirmed by SDS-PAGE
and ESI-MS analyses (Figure S4). Size exclusion chromatog-
raphy of the native complex indicated that Cya18 is a homo-
dimer. Qcn18 was obtained in essentially the same way.
Enzymatic reactions using several amino acids with the re-
combinant Cya18 were carried out in the presence of FeSO4,
a-ketoglutarate, and L-ascorbate. The resulting reaction mix-
tures were derivatized with dansyl chloride (DNS-Cl) and then
subjected to high-performance liquid chromatography (HPLC).
Surprisingly, we failed to detect any product in the assay, in
which we used L-Orn. After carrying out assays with various
amino acids, we found that Cya18 catalyzed the dehydrogena-
tion of L-Arg into L-(E)-4,5-dehydroarginine (6a, DArg) (Figure 5).
NMR spectra of the dansyl derivative 6b showed a pair of5, December 19, 2013 ª2013 Elsevier Ltd All rights reserved 1527
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Figure 4. Characterization of the Genes Involved in Biosynthesis of
Quinocarcin-Related Metabolites
(A) LC-MS analysis of the extracts from wild-type S. melanovinaceus DO-52
and various disruptants. Selected ions were monitored at m/z 331 (upper
trace) for quinocarcin (1) and at m/z 333 (lower trace) for quinocarcinol (3).
(B) LC-MS analysis of the extracts from qcn2/3 disruptant. Selected ions were
monitored at m/z 305 for 5b and m/z 319 for 5a.
(C) Structures of 5a and 5b isolated from qcn2/3 disruptant and putative
biosynthetic intermediate 5c.
See also Figures S1–S3 and Tables S2 and S5.
Figure 5. HPLC Analysis of the Enzymatic Reaction Products with
Cya18
The reaction mixture incubated with Cya18 was directly treated with dansyl-
chloride, and the resultant derivatives were analyzed. (i) Cya18 reaction
products. (ii) Negative control (incubated without Qcn18).
See also Figures S4 and S6 and Tables S3 and S4.
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4.50 ppm, indicating that the olefin is the E configuration, which
was further supported by the correlation in rotating frame nuclear
Overhauser enhancement spectroscopy analysis (Figure S4).
Next, we performed kinetic analysis of Cya18-mediated dehy-
drogenation to give the following kinetic parameters: Km = 8.46 ±Figure 3. Proposed Biosynthetic Pathways of Quinocarcin and SF-173
(A) Quinocarcin core scaffold assembly.
(B) SF-1739 core scaffold assembly.
(C) Quinocarcin late-stage pathway including isolated metabolites 5a and 5b fro
(D) Biosynthesis of aromatic amino acid 4.
See also Figure S9.
Chemistry & Biology 20, 1523–1530.09 mM, kcat = 12.8 ± 1.0 min
1, and kcat/Km = 1.51 mM
1
min1. Although we were successful in detecting the enzymatic
activity of Qcn18, aggregation of Qcn18 hampered its kinetic
characterization. To our knowledge, this is the rare example of
a-ketoglutarate-dependent dioxygenase catalyzing the dehy-
drogenation of the amino acid. Hydroxylation and dehydrogena-
tion reactions catalyzed by single-enzyme clavaminate synthase
2 have been reported (Zhou et al., 2001). This suggests that
Cya18-catalyzed dehydrogenation of L-Arg occurs by either
direct dehydrogenation or combined hydroxylation and dehy-
dration. Alignment between Cya18 and VioC, whose crystal
structure has been reported previously (Helmetag et al., 2009),
allowed us to identify several active site residues coordinating
L-Arg, Fe2+, and succinate. However, further experimental data
are required to discriminate the two reaction modes.
Functional Analysis of Quinocarcin NRPS
In the core scaffold assembly, the key C-C bond formations in
both Sfm and 1/2 occur at identical sites (Figure 1), indicating
that the NRPS system, similarly to the Sfm NRPSs, is involved
in 1/2 bond formation. Sfm NRPSs consist of four modules
(SfmA1/A2/B/C) (Li et al., 2008), whereas Qcn NRPS has five9
m S. melanovinaceus qcn2/3 disruptant.
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Figure 6. ATP-Inorganic Pyrophosphate Exchange Assay for Quino-
carcin NRPSs
(i) Various Qcn16/17/19 complex with selected amino acids.
(ii) various Qcn16/17/19 complex withDArg 6a prepared by incubation of L-Arg
with Qcn18.
(iii) partially purified Qcn19.
(iv) Qcn12A/16.
(v) Qcn13.
See also Figures S6–S8 and Tables S3 and S4.
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ering that a single-module NRPS, SfmC (C-A-PCP-R), catalyzed
condensation of two units of 4 (Figure 1B), we speculated that, in
the case of 1/2, the two NRPSmodules lacking the PCP domain,
Qcn17/Cya17 (C-A-PCP-R) and Qcn19/Cya19 (C0-A), catalyze
condensation of the last two extender units, m-Tyr/4 and DArg
(Figure 3A). The fact that the Qcn19/Cya19 C domain lost its
essential motifs, C1–C3 (Marahiel et al., 1997), suggests that
this domain is catalytically inactive (Figure S5); thus complex for-
mation of Qcn19 and Qcn17 is most likely key to two rounds of
Mannich-type condensation, as shown in Figure 3A. Domain
organization and sequence homology suggest that two modules
of SfmA1 (acyl loading didomain AL-ACP)/A2 (C-A-PCP) corre-
spond to Qcn13/Cya13 (AL-ACP)/Qcn12/Cya12 (C-A-PCP).
However, the remaining Qcn15/Cya15, lacking several motifs1530 Chemistry & Biology 20, 1523–1535, December 19, 2013 ª2013conserved from the A domain, did not show homology to
SfmB. Thus, Qcn15 is most likely responsible for incorporating
glycolic acid (Table S1; Figure S3).
Expression of all NRPSs as a hexahistidine-tagged protein
was examined under various conditions. We succeeded in effi-
cient expression of Qcn13 in E. coli and Qcn17 in actinomycetes
Rhodococcus erythropolis (Minami et al., 2012). However, either
the expression of other NRPSs was poor or the NRPSs formed
inclusion bodies (Figure S6). In the case of Qcn15/17/19, coex-
pression with the MbtH family protein member Qcn16 (Baltz,
2011) significantly improved the expression level and solubility
of target NRPSs, which were successfully copurified using a
Ni-NTA column, as was the case with other NRPSs (Davidsen
and Townsend, 2012, Felnagle et al., 2010; Zhang et al., 2010).
For expression of Qcn12, only truncated the Qcn12 A domain
coexpressed with Qcn16 was obtained, and in a limited amount
(Figure S6). When a mixture of histidine (His)-tagged Qcn16 and
Qcn17/19 from the transformant was purified using a Ni-NTA
column, large proteins Qcn17/19 (164/96 kDa, respectively)
without the His-tag coeluted with the small protein Qcn16
(8 kDa) in nearly equal amounts, indicating that these proteins
exist as a complex (Figure S6).
Initially, we examined the enzymatic activity of SfmC-like
NRPS Qcn17. Under conditions described previously (Koketsu
et al., 2010, 2012a, 2012b), N-mirystoyl-L-Ala-Gly-CoA with
Qcn17 was reduced to the expected aldehyde. This result indi-
cated that the Qcn17 R domain is capable of reducing a thioester
bound to the penultimate Qcn15 PCP. This feature is a charac-
teristic of THIQ NRPS (Figure S7) (Koketsu et al., 2010, 2012a,
2012b). To examine the amino acid/extender unit selectivity of
quinocarcin NRPS A domains, we employed an ATP-inorganic
pyrophosphate (ATP-PPi) exchange assay. Qcn13 with a puta-
tive acyl-CoA ligase (AL) domain utilized long-chain fatty acids
ranging from C14 to C18 in preference over C16 fatty acid (Fig-
ure 6). A partially purified Qcn12 A domain activated aliphatic
amino acids, including L-Ala. Bioinformatic analysis (Challis
et al., 2000; Stachelhaus et al., 1999) of the A domains of
Qcn12 predicted L-Ala (Table S1). The observed low specificity
of the Qcn12 A domain may reflect deletion of the C domain or
conformational damage of the expressed protein. As the bio-
infomatic prediction, Qcn15, whose A domain lacks the essential
motifs A1–A8 (Table S1, Figure S1), activated none of the amino
acids or glycolic acids with or without Qcn16.
ATP-PPi exchange assays of Qcn17 and Qcn19 were per-
formed under various conditions. When we used NRPS Qcn17
coexpressed with Qcn16, the Qcn16/17 complex selectively
activated 6a (Figure 6) but none of the other amino acids,
including L-Arg and m-Tyr. Qcn17 by itself did not show any
activity in conjunction with various amino acids. On the other
hand, Qcn16/19 revealed exchange activity specifically for
m-Tyr, but not for 3-methoxy-Phe. Qcn19 (partially purified) in
the absence of Qcn16 also showed specific activity for m-Tyr,
although Qcn19 and Qcn16 formed a complex, as shown by
purification with affinity chromatography. Interestingly, Qcn19
activated an alternative aromatic substrate 4 with an efficiency
similar to that of m-Tyr. C-C bond formation of substrates
derived from both aromatic amino acids occurs at the adjacent
position of the relevant hydroxy group, indicating that a free
hydroxy group is essential for the PS reaction in the biosynthesisElsevier Ltd All rights reserved
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the activity of the NRPS A domain is frequently correlated with
complex formation of these proteins (Davidsen and Townsend,
2012; Felnagle et al., 2010; Zhang et al., 2010). When we exam-
ined the A domain activity of the complex Qcn16/17/19, this
complex activated m-Tyr 11 times higher than 6a (Figure S8).
The independence of complex formation against adenylation
activity of two A domains was confirmed as follows. We pre-
pared A domain inactivation mutants by a point mutation of
conserved Lys residue in the P loop, which is proposed to involve
an interaction with the triphosphate group of ATP based on X-ray
data (Gocht and Marahiel, 1994; Yonus et al., 2008). Using two
mutants, Qcn17K644T and Qcn19K529T, we performed an
ATP-PPi assay of m-Tyr and 6a. Although mutations caused an
increase in the activity due to unknown reasons in both mutant
complexes, the relative activity (18.4) of the Qcn17 mutant com-
plex (m-Tyr) and the Qcn19mutant complex (DArg 6a) is compa-
rable to the relative activity (11.2) of the wild-type complex
(m-Tyr/6a), as shown in Figure S8. These results clearly show
that the complex formation itself did not affect the relative
ATP-PPi exchange activity of the A domains and that the
Qcn19 A domain inherently possesses much higher adenylation
activity than the Qcn17 A domain.
Proposed Mechanism of Core Scaffold Assembly
On the basis of experimental data obtained in this study, we can
now propose the reaction pathway for the construction of the
quinocarcin tetracyclic core scaffold, as shown in Figure 3A.
As in the case of saframycin biosynthesis, the initial two
modules, Qcn13/12, load long-chain fatty acids and L-Ala,
respectively (Koketsu et al., 2010). Because the Qcn15 A domain
is functionally inactive, an alternative enzyme is required for
loading the glycolyl unit on the ACP (Qcn8) derived from D-xylu-
lose-5-phosphate (Qcn7/9) to Qcn15-PCP (Peng et al., 2012). In
the biosynthesis of tetronate antibiotic RK-682, the KASIII homo-
log RkE catalyzes the transferring glyceryl unit to the stand-alone
ACP RkF after self-loading the glyceryl unit (Sun et al., 2010).
This suggests that a KASIII homolog, Qcn10, may possess
similar acyl unit-loading activity. The Qcn15 C domain con-
denses the resultant glycolyl unit andN-fatty acyl-L-Ala unit teth-
ered to Qcn12-PCP, resulting in a linear thioester intermediate
on Qcn15-PCP that is reductively cleaved by the Qcn17 R
domain to give aldehyde 7 as in the case of model substrate
N-myristoyl-L-Ala-Gly-CoA (S1).
The key step in the quinocarcin core assembly is the reaction
involving two unusual amino acids: m-Tyr and DArg 6a. The
results of the ATP-PPi exchange assay showed that Qcn17
and Qcn19 activate 6a and m-Tyr, respectively, and that m-Tyr
is predominantly activated over 6a. In the Qcn17/19 complex,
adenylated m-Tyr with Qcn19 is transferred to Qcn17-PCP,
followed by Qcn17 PS domain-catalyzed condensation with
long-chain fatty acyl-L-Ala-glyoxal 7 and reductive cleavage to
produce bicyclic aldehyde 8 (Figure 3A). After accumulation of
a sufficient amount of 8, the Qcn17-PS domain catalyzes the
intramolecular Mannich reaction of 8 and Qcn17-PCP-tethered
6a provided by less effective adenylation of the Qcn16/17 com-
plex to afford a tetracyclic intermediate possessing a pyrrolidine
ring. The nonenzymatic hydrolytic cleavage of the guanidium
imine and reductive release followed by spontaneous cyclizationChemistry & Biology 20, 1523–153furnish quinocarcin core scaffold 9. The exact reaction sequence
at the final transformation is not obvious at this stage. Unproduc-
tively loaded 6a onto Qcn17-PCP may be cleaved off by Type II
thioesterase Qcn14. This possibility was supported by the
result that a Dqcn14 mutant significantly reduced quinocarcin
production.
In the SfmC reaction (Figure 1B), a large amount of bicyclic
aldehyde intermediate was not accumulated, suggesting that
the PS reaction is not a rate-determining step (Koketsu et al.,
2010, 2012a, 2012b). However, the bicyclic aldehyde 8 is likely
to be accumulated, reflecting significantly different adenylation
activity of Qcn17-A and Qcn19-A. Because a tight complex of
MbtH protein and the NRPS A domain is usually essential for
certain adenylation activity, to the best of our knowledge, sup-
port for the fact that the Qcn16/19 complex is unrelated to this
activity is sparse (Felnagle et al., 2010; Zhang et al., 2010).
This points out a possibility that dynamic control of the interac-
tion among Qcn16, Qcn17, and Qcn19 contributes to regulate
m-Tyr/6a activation with Qcn16/17/19 complex. Further data
are necessary to solve this intriguing issue in the novel NRPS-
catalyzed reaction.
In the SF-1739 gene cluster, we found all genes required for
core skeleton biosynthesis (the NRPS-related genes cya12/13/
15/16/17/19 and the KASIII homolog cya23 corresponding to
the relevant qcn genes). Thus, essentially the same mechanism
can be applied to the SF-1739 core scaffold assembly affording
10 just by changing the aromatic amino acid fromm-Tyr to 4 and
the number of L-Ala residues in the linear acylpeptidyl aldehyde
from one to three units (Figure 3B). The only difference between
the core scaffolds of 9 and 10 is the C-10 stereochemistry on the
pyrrolidine ring newly introduced by the intramolecular Mannich
reaction. On the basis of previous reports on the quinocarcin
synthesis using a similar intramolecular pyrrolidine ring formation
(Hiemstra et al., 1988; Magnus and Matthews 2005; Wu et al.,
2008), we speculate that the Cya17 PS domain selectively stabi-
lized the unfavorable transition state affording 10.
Late-Stage Biosynthetic Modifications
The proposed common mechanism in quinocarcin/SF-1739
skeletal construction involved 11 functionally common genes
(Table 1, genes indicated boldface). Exclusion of resistant/
regulatory genes (qcn6/20–24) and Type II thioesterase genes
(qcn14) leaves genes (qcn1/2/3/5/11) for modification of the
core scaffold 9 (Table 1 and Table S1). In the biosynthesis of 1,
accumulation of 5a and 5b, putative reduced products of 5c,
upon inactivation of gene qcn2/3 suggested that O-methylation
(Qcn5) and deacylation (Qcn1) precede oxidation of aldehyde
functionality (Qcn2/3). Isolation of N-desmethyl analogue 5a
implicated that N-methylation (Qcn11) occurs at the final stage.
Considering these results, we can reasonably speculate the late-
stage biosynthesis of 1, as shown in Figure 3C.
The late-stage biosynthesis of SF-1739 (2) is rather different
from that of quinocarcin (Figure S9). Transformation of core scaf-
fold 10 to 2 requires aminoacetal formation, p-hydroxylation
(Cya27, a homolog of SacJ), oxidation to orthoquinone methide
(Cya6, flavin adenine dinucleotide-dependent monooxygenase),
and the subsequent spontaneous C-N bond-forming cyclization
in addition to deacylation (Cya21) and N-methylation (Cya5).
Some of the reactions are readily assigned to relevant genes5, December 19, 2013 ª2013 Elsevier Ltd All rights reserved 1531
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genes. The exact order of the reaction sequence is not available
at this stage. Biochemical studies with the indicated enzymes
are necessary to establish this hypothesis.
SIGNIFICANCE
The potent antitumor antibiotics quinocarcin and SF-1739
comprise a family of THIQ alkaloids and share a common
tetracyclic THIQ-pyrrolidine core scaffold. We describe
herein the identification of biosynthetic gene clusters, a pre-
viously uncovered amino acid substrate dehydroarginine for
the pyrrolidine ring by characterization of a-ketoglutarate-
dependent dioxygenase Qcn18/Cya18, and the substrate
specificity of the five NRPS adenylation domains using the
ATP-PPi exchange assay. In addition, a multicomponent
NRPS complex Qcn17/19, including the MbtH protein
Qcn16 suggested by chromatographic behavior and prefer-
ential activation of m-Tyr over dehydroarginine, allowed us
to propose a complex core assembly mechanism for quino-
carcin and SF-1739 involving a sequential PS reaction and an
intramolecular Mannich reaction. This mechanism differs
from a reported mechanism of bisTHIQ core assembly of
structurally related saframycin in view of switching of A
domain activity with assistance of the MbtH protein. Our
proposal regarding the biosynthesis of 1 and 2 may be
applied to the biosynthesis of other THIQ-pyrrolidine anti-
tumor antibiotics, including quinocarcin-related tetrazo-
mine (Sato et al., 1991), lemonomycin (He et al., 2000), and
SF-1739-related dnacin (Hida et al., 1994) and aclidinomycin
(Cang et al., 2001). The mechanism will provide useful
information on genetic engineering of both bisTHIQ and
THIQ-pyrrolidine antitumor antibiotics to generate hybrid
molecules possessing more potent antitumor activities.
EXPERIMENTAL PROCEDURES
Fermentation
S. griseoplanus SF-1739 was grown in a baffled shake flask (500ml) containing
100 ml of maltose-yeast extract-malt extract broth (4 g of maltose, 5 g of yeast
extract, and 10 g of malt extract per liter of water). S. melanovinaceus DO-52
was grown in the baffled shake flask (500 ml) containing 100 ml of quinocarcin
production broth (50 g of glucose, 20 g of Soytone, Bacto soy peptone [BD
Diagnostics], 0.3 g of KH2PO4, 0.4 g of K2HPO4, and 0.2 g of MgSO4-7H2O
per liter of water [pH 7.0]). Fermentations were carried out for 2 to 7 days at
30C with agitation.
Disruption of qcn Genes
qcn1, 2/3, 7, 14, and 19 were disrupted by a double-crossover event, espe-
cially disruption of qcn14, which was performed by in-frame deletion. DNA
fragments (2.5–4.0 kb) that carried upstream and downstream regions of the
target gene were amplified by PCR (Table S2 available online). These frag-
ments and the thiostrepton resistance gene, tsr, which was prepared from
pIJ702 as a BclI fragment, were inserted into appropriate restriction enzyme
sites of pWHM3, as shown in Figures S1A and S1B. The constructed plasmid
was purified from S. lividans TK23 and digested with HindIII and DraI. The
resultant linear plasmid was used to transform S. melanovinaceus DO-52.
Thiostrepton-resistant colonies were selected as candidates for disruptants.
Gene disruption was confirmed by PCR analysis (Figure S1C and Table S2).
Next, to examine quinocarcin production, the culture medium of the disruptant
was analyzed by liquid chromatography-mass spectrometry (LC-MS). The
analytical conditions were as follows: ZORBAX Eclipse XDB C18 column1532 Chemistry & Biology 20, 1523–1535, December 19, 2013 ª2013(5 mm, 2.1 3 50 mm; Agilent Technologies) with a column temperature of
30C in mobile phase, a linear gradient from 30% to 90% acetonitrile +
0.1% formic acid for 0–20 min, an isocratic 90% for 20–25 min, a linear
gradient from 90% to 30% for 25–26 min, and 30% acetonitrile + 0.1% formic
acid for an additional 14 min at a flow rate of 0.2 ml/min.
Purification of the Accumulated Metabolites 5a and 5b from the
qcn2/3 Disruptant
The qcn2/3 disruptant was grown in a baffled shake flask (500 ml) containing
100 ml of quinocarcin production broth. Fermentation was carried out for
1 week at 30Cwith agitation. The culture broth (3 l) was centrifuged to remove
the cells. The supernatant was subjected to AMBERLITE FPC3500 resin chro-
matography (300ml bed volume; DowWater & Process Solutions), and the col-
umn was washed with Milli-Q water (3 l; EMD Millipore). The materials were
eluted with 2 M ammonium acetate (1.8 L), and eluted fractions containing
5a and 5b were passed through a Diaion HP-20 resin column (600 ml bed
volume; Mitsubishi Chemical). After the columnwas washed with Milli-Q water
(2.5 l), the hydrophobic materials were eluted with 1 l of methanol, then evap-
orated to dryness under reduced pressure. The residue was dissolved in a
small volume of Milli-Q water and purified by preparative scale HPLC
(Wakosil-II 5C18 column [10 mm3 250 mm]; Wako Pure Chemical Industries)
with a column temperature of 30C and a flow rate of 3 ml/min using a linear
gradient from 15% to 17% acetonitrile/50 mM ammonium acetate (pH 5.0)
for 0–18 min, 17% to 80% for 18–20 min, 80% to 15% for 20–22 min, and
15% acetonitrile/50 mM ammonium acetate (pH 5.0) for an additional 8 min.
The fractions containing 5a were further purified by semipreparative HPLC
(Wakosil-II 5C18 column [4.6 mm3 250 mm; Wako Pure Chemical Industries])
with a column temperature of 30C in the mobile phase in an isocratic column
with 12% acetonitrile/20 mM ammonium acetate (pH 5.0) for 30min and a flow
rate of 1 ml/min. The fractions containing 5b were further purified under the
same conditions (column, temperature, and flow rate) as those used for 5a,
but with a linear gradient from 10% to 20% acetonitrile/20 mM ammonium
acetate (pH 5.0) for 0–15 min, 20% to 40% for 15–20 min, 20% to 40% for
15–20 min, 40% to 80% for 20–22 min, 80% to 10% for 22–23 min, and
10% acetonitrile/20 mM ammonium acetate (pH 5.0) for an additional 9 min.
In the condition for purification of 5b, the retention times of 5a and 5b were
15.0 min and 17.6 min, respectively. The resultant compounds were desalted
with Sep-Pak C18 Plus Short Cartridge (Waters) to give the following results for
5a (1.2 mg) and 5b (2.1 mg):
5a: [a]23D 69.0 (c 0.005, MeOH); ESI-HR-MS (positive) calculated for
C17H24N2O3 ([M+H]
+), 305.1860, found m/z 305.1854 and
5b: [a]23D 52.3 (c 0.008, MeOH); ESI-HR-MS (positive) calculated for
C18H26N2O3 ([M+H]
+), 319.2016, found m/z 319.2020.
1H and 13C NMR data are summarized in Table S5.
Cloning, Overexpression, and Purification of Qcn Proteins
To overproduce the recombinant proteins Qcn12-A, 13, 15, 15-A-PCP, 16, 17,
17K644T, 18, 19, 19K529T, and Cya18, qcn genes and cya18 were amplified
from genomic DNA of S. melanovinaceus DO-52 and S. griseoplanus SF-
1739, respectively, by PCR with sets of primers (Table S3 ). For the construc-
tion of qcn17 K644T and qcn19 K529T, sets of primers with point mutations
were used. The amplified PCR products were inserted into each expression
plasmid by Ligation high ver.2 (Toyobo) or the In-Fusion HD Cloning Kit
(Clontech Laboratories/Takara Bio), and those sequences were confirmed
by sequencing. Qcn13, Qcn16, and Cya18 were expressed in E. coli BL21-
Gold(DE3) (Agilent Technologies) as N-terminal His-tag fused proteins. The
expression conditions for the recombinant enzymes were set as described
in the manufacturer’s protocols for the pET28b (Novagen) and pCold I DNA
Cold Shock (Takara Bio) expression systems. The other Qcn proteins were ex-
pressed in R. erythropolis L88. Transformation of R. erythropolis L88 by each
pTip plasmid was performed using an electroporation system according to the
methods described by Nakashima and Tamura (2004). Transformants
harboring pTip plasmids were grown at 30C in Luria-Bertani medium with
tetracycline (10 mg/ml) and/or chloramphenicol (15 mg/ml). Expression of
Qcn proteins was induced by adding 1 mg/ml thiostrepton when the optical
density at 600 nm reached about 0.6, and cultivation was continued for anElsevier Ltd All rights reserved
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harvested by centrifugation, resuspended in lysis buffer (20 mM Tris-HCl,
300 mM NaCl, 5 mM imidazole, and 20% glycerol; pH 8.0) and sonicated for
30 s ten times on ice and centrifuged at 20,000 3 g for 20 min at 4C. The
supernatant was packed into a column with 2 ml of Ni-NTA agarose resin
(QIAGEN) and mixed gently in a shaker for 1 hr at 4C. The protein-bound resin
was washed with 10 ml of wash buffer 1 (20 mM Tris-HCl, 300 mM NaCl,
20 mM imidazole, and 20% glycerol; pH 8.0) and 8 ml of wash buffer 2
(20 mM Tris-HCl and 20% glycerol; pH 8.0), then the protein was eluted with
8 ml of elution buffer (20 mM Tris-HCl, 500 mM imidazole, and 20% glycerol;
pH 8.0). The combined fraction (3 ml) was desalted with a PD-10 Desalting
Column (GE Healthcare Bio-Sciences) equilibrated with storage buffer
(20 mM Tris-HCl and 20% glycerol; pH 8.0). The purity of Qcn proteins was
analyzed by SDS-PAGE. The protein concentration was determined by Quick
Start Bradford protein assay (Bio-Rad Laboratories) using BSA as a standard.
The identity of purified Cya18 was confirmed by ESI-MS analysis, as shown in
Figure S4.
Enzyme Assay for Nonheme Iron Oxygenase Cya18
A standard assay was conducted as follows. The reaction mixture (300 ml),
containing 500 mM arginine, 1 mM a-ketoglutarate, 0.1 mM FeSO4, 0.1 mM
ascorbate, 0.5 mM dithiothreitol (DTT), and 0.1 mg/ml BSA in 50 mM 3-(N-
morpholino)propanesulfonic acid (MOPS) (pH 7.0), was preincubated at
25C for 10 min. The reaction was started by the addition of 500 nM Cya18
and incubated for 1 hr. The 25 ml of the reaction mixture were treated with
20 ml of 1 mg/ml DNS-Cl dissolved in CH3CN and 20 ml of 80 mM Li2CO3
(pH 10) at room temperature (RT) for 1 hr. After excess DNS-Cl was reacted
with 2% ethylamine solution (10 ml) at RT for 30 min, the mixture was centri-
fuged and the resultant supernatant was added to 15 ml of water and subse-
quently analyzed by HPLC with an Eclipse XDB-C18 column (150/4.6, 5 mm
particle size; Agilent Technologies) under an isocratic elution with 20% of
CH3CN in 20 mM NH4OAc (pH 5.5) at a flow rate of 0.5 ml/min at 30
C. The
substrate and the product were monitored at a wavelength of 330 nm.
Isolation of Cya18-Catalyzed Reaction Product 6b
A preparative scale reaction was carried out as follows. The reaction mixture
(10 ml), containing 1 mM arginine, 1 mM a-ketoglutarate, 0.1 mM FeSO4,
0.1 mM ascorbate, 0.5 mM DTT, 0.1 mg/ml BSA, and 5 mM Cya18 in 50 mM
HEPES (pH 7.5), was incubated at 30C for 4 hr. The reaction was quenched
by the addition of cold ethanol (10 ml) and centrifuged at 12,000 3 g for
10 min. Next, we added 80 mM Li2CO3 (20 ml) and 1.5 mg/ml DNS-Cl
(10 ml) to the resultant supernatant. After incubation at RT for 1 hr, excess
DNS-Cl was treated with 2% ethylamine solution (8 ml) at RT for 30 min. The
mixture was adjusted to pH 7.5 with 1 N HCl and then lyophilized. The crude
material was dissolved in 20% CH3CN in 2 ml of 50 mM NH4OAc (pH 5.5)
and purified by HPLC equipped with a Wakosil-II 5C18 column (10 3
250 mm, 5 mm particle size) containing an isocratic elution with 20% of
CH3CN in 20 mM NH4OAc (pH 5.5) at a flow rate of 4.0 ml/min and UV at
330 nm to give N-dansyl-L-(E)-4,5-dehydroarginine (6b; 465 mg, 27% yield).
The yield was calculated based on the integral ratio of the 1H NMR spectra
with DMSO employed as an internal standard. 1H NMR (600 MHz, D2O);
d 1.8 (6H, s), 2.0 (1H, dt, J = 8.9, 14.6 Hz, and 3-Ha), 2.13–2.17 (1H, m, and
3-Hb), 3.5 (1H, dd, J = 3.8, 9.2 Hz, and 2-H), 4.5 (1H, dt, J = 7.2, 13.5 Hz,
and 4-H), 5.51 (1H, d, J = 13.5 Hz, and 5-H), 7.28 (1H, d, J = 7.6 Hz), 7.58
(2H, q, and J = 8.7 Hz), 8.17 (2H, d, and J = 7.6 Hz), and 8.39 (1H, d, and
J = 8.7 Hz). Electrospray ionization high-resolution mass spectrometry (ESI-
HR-MS) (positive) was used to calculate C18H24N5O4S [M+H]
+ 406.1525,
which produced a result of 406.1549.
Kinetic Analysis for Cya18-Catalyzed Reaction
The steady-state kinetic parameter was determined by HPLC using 9-fluore-
nylmethyl chloroformate (Fmoc) derivatization of the reaction mixtures. A
series of reactions (200 ml) containing 50 nM Cya18, 1 mM a-ketoglutarate,
0.1 mM FeSO4, 0.1 mM ascorbate, 0.5 mM DTT, 0.1 mg/ml BSA, and 73
L-arginine (2.5–100 mM) in 50 mM MOPS (pH 7.0) were carried out at 25C.
After incubation for 1 min, each 50 ml of the mixtures were added to 3 mM
Fmoc-Cl solution in 100 ml of acetone and 50 ml of 0.2 M borate buffer
(pH 8.4). The reaction mixtures were reacted at RT for 1 min, then excessChemistry & Biology 20, 1523–153Fmoc-Cl was removed by extraction with 23 pentane (0.4 ml). After acetone
was evaporated in reduced pressure, the mixtures were added to 10 ml of
CH3CN and subsequently analyzed by HPLC. The amounts of conversion
were estimated on the basis of the integral ratios of the peak of Fmoc-L-Arg
versus Fmoc-L-dehydro-Arg monitoring at 270 nm. The extinction coefficients
at 270 nm were assumed to be the same for Fmoc-L-Arg and Fmoc-L-dehy-
dro-Arg. The reactions were carried out in triplicate. The obtained data
were fitted to the Michaelis-Menten plot by nonlinear regression using the
ANEMONA.XLT Excel template to determine the kcat and the Km
app values.
ATP-[32P]PPi Exchange Assay
ATP-PPi exchange assays were performed in 100 ml of 50 mM NaH2PO4-
NaOH (pH 7.5) buffer containing 1 mM substrate, 2 mM ATP, 5 mM DTT,
0.2 mM EDTA, 0.1 mg/ml BSA and 1 mM [32P]PPi (0.2 mCi/M). The reactions
were started by the addition of the 1 mM enzyme. After the incubation at
37C for 15min, the reactions were quenched by adding 500 ml of stop solution
(1.2% activated charcoal, 0.1 M tetrasodium pyrophosphate, and 0.56 M
HClO4). The charcoal was precipitated by centrifugation and washed twice
with 500 ml of wash solution (0.1 M tetrasodium pyrophosphate, 0.56 M
HClO4). Charcoal bound by ATPwas resuspended in 500 ml of water, and, after
the addition of 500 ml of Insta-Gel Plus (PerkinElmer), radioactivity was
measured by using the LS6500 Multipurpose Scintillation Counter (Beckman
Coulter). In the Qcn17 assay, the required substrate was prepared as follows.
A standard reaction mixture (1 ml) containing 200 mM Tris-HCl buffer (pH 8.0),
2 mM arginine, 4 mM a-ketoglutaric acid, 100 mM FeSO4, 100 mM ascorbic
acid, and 5 mM purified Qcn18 was incubated at 30C for 4 hr, then proteins
were removed by ultrafiltration with a 0.5 ml sample (Amicon Ultra Centrifugal
Filter Unit; EMD Millipore). After estimation of 6a concentration, the resultant
supernatant (50 ml) was used to perform an ATP-PPi exchange reaction
(100 ml).
Enzyme Assay for Qcn17-R Domain
Preparation of holo-Qcn17 was carried out as follows. A reaction mixture of
40-phosphopantetheinylation containing 20 mM purified Qcn17, 100 mM CoA,
10 mM MgCl2, 1.0 mM recombinant Bacillus subtilis, and 4
0-phosphopante-
theine transferase Sfp in 50 mM KH2PO4-KOH (pH 7.5) buffer was incubated
at RT for 20 min. A standard reaction mixture of Qcn17 R domain (100 ml) con-
taining 50 mM KH2PO4-KOH (pH 7.4) buffer, 0.5 mM N-myristoyl-L-Ala-Gly-
CoA (S1), 3 mM NADH, 3 mM NADPH, 10 mM MgCl2, 10 mM MnCl2, and
1.2 mM apo/holo-Qcn17 was incubated at 30C for 10 hr. The reaction
was quenched by the addition of acetonitrile (100 ml) and centrifuged at
12,000 3 g for 10 min, then the resultant supernatant was analyzed by LC-
MS to detect the reaction product S2 (Figure S5). The analytical conditions
were as follows: ZORBAX Eclipse XDB-C18 column (5 mm, 2.1 3 50 mm)
(Agilent Technologies) at 30C, mobile phase linear gradient from 30% to
80% acetonitrile + 0.1% formic acid for 0–20 min, an isocratic 80% for
20–25 min, a linear gradient from 80% to 30% for 25–26 min, and 30%
acetonitrile + 0.1% formic acid for an additional 14 min, and a 0.2 ml/min
flow rate.
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